Research Map
The live state of the reviewed evidence — 4 published studies (1 human), 2 cancer pages, and 0 evidence verdicts. Educational only; not medical advice.
Most-studied medicines & supplements (human evidence)
- Carboplatin · 1 human study
- Paclitaxel · 1 human study
- Ifosfamide · 1 human study
Clinical-trial reports
- Randomized Phase III Trial of Paclitaxel and Carboplatin Versus Paclitaxel and Ifosfamide in Patients With Carcinosarcoma of the Uterus or Ovary: An NRG Oncology Trial · Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2022
- Primary ovarian rhabdomyosarcoma in children · Pediatric surgery international · 2008
What changed recently
- New compound addedDoxorubicin
- New compound addedActinomycin D
- New compound addedCyclosporin A
- New compound addedVincristine
- New compound addedCyclophosphamide
- Cancer page updatedOvarian carcinosarcoma
- Cancer page updatedOvarian rhabdomyosarcoma
- New compound addedPaclitaxel
- New compound addedCarboplatin
- New compound addedIfosfamide
- New compound addedRelacorilant
- New cancer type addedFallopian Tube Cancer
- New cancer type addedOvarian Epithelial Carcinoma
- New cancer type addedUterine Carcinosarcoma
How this is built
Every number and link here is drawn from human-approved, published content — nothing is estimated. Read how we review, or jump into the study feed.